Quotes 5-day view Delayed Bolsas Y Mercados Espanol…
10/22/2021
10/25/2021
10/26/2021
10/27/2021
10/28/2021
Date
20.2(c)
20.44(c)
20.33(c)
19.85(c)
19.84 Last
717 568
908 961
498 535
651 615
607 183 Volume
-0.93% +1.19% -0.54% -2.36% -0.05% Change
Estimated financial data (e) EUR USD
Sales 2021
5 283 M 6 131 M 6 131 M
Net income 2021
556 M 646 M 646 M
Net Debt 2021
6 052 M 7 024 M 7 024 M
P/E ratio 2021
24,0x
Yield 2021
1,61%
Sales 2022
5 741 M 6 663 M 6 663 M
Net income 2022
716 M 831 M 831 M
Net Debt 2022
5 880 M 6 824 M 6 824 M
P/E ratio 2022
18,7x
Yield 2022
1,76%
Capitalization
11 425 M 13 240 M 13 259 M
EV / Sales 2021
3,31x
EV / Sales 2022
3,01x
Nbr of Employees
23 431
Free-Float
79,7%
Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. It organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end...
All news about GRIFOLS, S.A.
10/26 GRIFOLS S A : earns approval for the voluntary public tender offer of Biotest and advances..PU
10/26 GRIFOLS S A : October 26, 2021Grifols earns approval for the voluntary public tender offer..PU
10/20 GLOBAL MARKETS LIVE : Kering, Netflix, Roche, United Airlines, Xiaomi...10/19 GRIFOLS S A : Egypt Launch 1st African Plasma-Supply PlatformMT
10/19 Grifols and Egypt Inaugurate First African Plasma-Supply Platform, in Cairo, as Part of.. CI
10/19 GRIFOLS S A : and Egypt inaugurate first African plasma-supply platform, in Cairo, as part..PU
10/18 European ADRs Move Lower in Monday Trading MT
10/13 GRIFOLS S A : increases access to plasma-derived therapies as part of its commitment to do..PU
10/13 GRIFOLS S A : October 13, 2021Grifols increases access to plasma-derived therapies as part..PU
10/12 European ADRs Slightly Higher Tuesday Morning, Led by Biotechs MT
10/11 European ADRs Move Higher in Monday Trading MT
10/08 European ADRs Move Higher in Friday Trading MT
10/06 GRIFOLS S A : Citigroup Upgrades Grifols to Buy from NeutralMT
10/06 GRIFOLS S A : divests its hemostasis technology business for USD 25 millionPU
10/06 GRIFOLS S A : October 6, 2021Grifols divests its hemostasis technology business for USD 25..PU
News in other languages on GRIFOLS, S.A.
10/26 EN DIRECTO DESDE LOS MERCADOS : Enagás, Grifols, Nordea, Samsung Heavy, Facebook, UBS, Gee..10/26 Tesla y Facebook en modo fuego cruzado 10/26 GRIFOLS S A : recibe la aprobación a la OPA voluntaria sobre Biotest y avanza en su estrat..10/26 GRIFOLS S A : 26 octubre 2021Grifols recibe la aprobación a la OPA voluntaria sobre Biotes..10/20 EN DIRECTO DESDE LOS MERCADOS : Grifols, Iberdrola, Tencent, ASML, Nestlé, Burberry, Faceb..
Analyst Recommendations on GRIFOLS, S.A.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends GRIFOLS, S.A.
Short Term Mid-Term Long Term Trends Bearish Bearish Bearish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
19,85 €
Average target price
26,66 €
Spread / Average Target
34,3%
Please enable JavaScript in your browser's settings to use dynamic charts.
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
